Abstract
COVID-19 is an emerging disease that is a major threat to the global community. The main challenge in this disease is the lack of proper or proven medication. The drugs used to treat this disease are only for symptomatic treatment. Studies of other coronaviruses, such as SARS and MERS, suggest that quercetin has sufficient potential to treat COVID-19. Previous studies have shown that quercetin reduces the entry of the virus into the cell by blocking the ACE2 receptor, as well as reducing the level of interleukin-6 in SARS and MERS patients. Therefore, the aim of this review was to scrutinize the potential of quercetin as a drug in the treatment of COVID-19 from a molecular perspective.
Keywords: Quercetin, therapeutic, COVID-19, ACE2, SARS, MERS.
Related Books
Biochemical and Biological Effects of Organotins
Glucose Homeostasis and Insulin Resistance
Synthesis and Biological Applications of Glycoconjugates
GPI Membrane Anchors – The Much Needed link
Biology and Chemistry of Beta Glucan Vol: 1 Beta Glucans - Mechanisms of Action
Free Radical Biomedicine: Principles, Clinical Correlations, and Methodologies
Sialobiology: Structure, Biosynthesis and Function. Sialic Acid Glycoconjugates in Health and Disease
Biology and Chemistry of Beta Glucan Volume Title: Beta-Glucan, Structure, Chemistry and Specific Application
MCQs Series for Life Sciences
Inositol & its Phosphates: Basic Science to Practical Applications
55